Abstract:Objectives: To identify relationships between vitamin D serum levels and the presence of autoantibodies directed against vitamin D and levels of interleukin(IL)-17 and IL-23 in patients with systemic lupus erythematosus (SLE). Methods: The study included 49 patients with SLE. Serum concentrations of 25(OH)D 3 were measured with electrochemiluminescence immunoassay (ECLIA). Enzyme-linked immunosorbent assays (ELISA) were used to determine antibodies directed against 1,25(OH) 2 D 3 and levels of IL-17 and IL-23 in serum of SLE patients. In evaluation of vitamin D status, the control group consisted of 49 age and gender matched healthy individuals, whereas in assessment of anti-vitamin D antibodies the control group comprised 30 sera from blood donors. Results: Serum concentration of 25(OH)D 3 in SLE patients during the warm season was 18.47 ± 9.14 ng/ml, which was significantly decreased as compared with that of the control group – 31.27 ± 12.65 ng/ml ( p = 0.0005). During the cold season a trend toward lower concentration of 25(OH)D 3 in SLE patients was revealed; however, it did not reach statistical significance (11.71 ± 7.21 ng/ml vs. 16.01 ± 8.46 ng/ml; p = 0.054). Results within the recommended range for vitamin D (30–80 ng/ml; 70–200 nmol/l) were observed only in three patients. The 25(OH)D 3 concentration was decreased in SLE patients with renal disease or leucopenia as compared with the levels in patients who did not have either problem ( p = 0.006 and p = 0.047, respectively). The cold season was found to be a risk factor for vitamin D deficiency (<20 ng/ml) (odds ratio = 9.25; p = 0.005). Autoantibodies directed against 1,25(OH) 2 D 3 were detected in three SLE patients. No significant difference in 25(OH)D 3 serum concentrations was found between SLE patients with and without these autoantibodies. No link was shown between the existence of autoantibodies against 1,25(OH) 2 D 3 and clinical or laboratory findings, including IL-17 and IL-23 levels. However, serum concentrations of IL-23 were lower in patients with vitamin D deficiency ( p = 0.037). Conclusions: SLE patients, especially those with leucopenia or renal involvement, are at high risk of vitamin D deficiency and require vitamin D supplementation. Some SLE patient sera contained 1,25(OH) 2 D 3 antibodies, but these antibodies do not appear to affect vitamin D levels.

Serum vitamin D level in patients with systemic lupus erythematosus and its relationship with bone mineral density

The Correlation Between the Serum Collagen Type Ⅳ and Laminin Levels and Disease Activity in Systemic Lupus Erythematosus

Factors Associated with 25-Hydroxyvitamin D Level in Chinese Hospitalized Patients with Systemic Lupus Erythematosus: a Retrospective Cohort Study

Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis

Clinical Implication of Levels of Serum Collagen Type Ⅳ and Laminin in Systemic Lupus Erythematosus

Vitamin D and systemic lupus erythematosus: Causality and association with disease activity and therapeutics

Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters

The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus

Study of Bone Mineral Density and Serum Bone Turnover Markers in Newly Diagnosed Systemic Lupus Erythematosus Patients

[Association of Vitamin D Concentrations with Juvenile Idiopathic Arthritis].

Serum RANKL, OPG and Vitamin D in Children with Systemic Lupus Erythematosus

Clinical analysis of bone mineral density in patients with newly diagnosed untreated systemic lupus erythematous

Vitamin D in active systemic lupus erythematosus and lupus nephritis: a forgotten player

Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha

Metabolic Alterations in Vitamin D Deficient Systemic Lupus Erythematosus Patients

Determinants of bone mineral density in systemic lupus erythematosus

The relationship between vitamin D status and disease activity in Iraqi systemic lupus erythematosus patients

[Associations between vitamin D levels and systemic lupus erythematosus risk:a Mendelian randomized study]

Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation

The changes of Treg and Th17 cells relate to serum 25(OH)D in patients with initial-onset childhood systemic lupus erythematosus

Relationship of serum and dietary vitamin D with high cardiometabolic risk in Mexican systemic lupus erythematosus patients: A cross-sectional study